Selection of aptamers with high affinity and high specificity against C595, an anti-MUC1 IgG3 monoclonal antibody, for antibody targeting

Journal of Immunological Methods

Volumn 296, Issue 1-2, 2005, Pages 45-62

  Missailidis, Sotiris ^a   Thomaidou, Despina ^b   Borbas, K Eszter ^a   Price, Mike R ^b  

^a OPEN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Anti idiotypic targeting; Antibodies; Aptamers; C595; Fluorescence; FRET; SELEX

Indexed keywords

APTAMER; IMMUNOGLOBULIN G3; MONOCLONAL ANTIBODY; PEPTIDE;

ADSORPTION; ANTIBODY AFFINITY; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; DENATURATION; DIAGNOSTIC PROCEDURE; ELUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; IMAGING; IMMUNOASSAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; BINDING, COMPETITIVE; CA-15-3 ANTIGEN; COMBINATORIAL CHEMISTRY TECHNIQUES; DIRECTED MOLECULAR EVOLUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE LIBRARY; HUMANS; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES; POLYMERASE CHAIN REACTION; PROTEIN CONFORMATION;

EID: 12944304157     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.10.011     Document Type: Article

References (53)

1. J.M. Bacher, and A.D. Ellington Nucleic acid selection as a tool for drug discovery Drug Discov. Today 3 1998 265
2. A. Bianchi, and M. Massaia Idiotypic vaccination in B-cell malignancies Mol. Med. Today 3 1997 435
3. H. Bohlen, K. Thielemanns, H. Tesch, A. Engert, H.J. Wolf, B. vanCamp, J. Urbain, and V. Diehl Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype X anti-class II antibodies can protect against tumor growth Cytokines Mol. Ther. 2 1996 231
4. C.B. Caspar, S. Levy, and R. Levy Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: comparison of different vaccine formulations Blood 90 1997 3699
5. J. Ciesiolka, M. Illangasekare, I. Majerfeld, T. Nickles, M. Welch, M. Yarus, and S. Zinnen Affinity selection-amplification from randomized ribooligonucleotide pools Method Enzymol. 267 1996 315
6. L. Connolly, T.L. Fodey, S.R.H. Crooks, P. Delahaut, and C.T. Elliott The production and characterisation of dinitrocarbanilide antibodies raised using antigen mimics J. Immunol. Methods 264 2002 45
7. R.C. Conrad, L. Giver, Y. Tian, and A.D. Ellington In vitro selection of nucleic acid aptamers that bind proteins Method Enzymol. 267 1996 336
8. T.A. Davis, D.G. Maloney, D.K. Czerwinski, T.M. Liles, and R. Levy Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone Blood 92 1998 1184
9. P. Deitiker, T. Ashizawa, and M.Z. Atassi Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of myasthenia gravis? Hum. Immunol. 61 2000 255
10. J. DeJonge, C. Heirman, M. DeVeerman, S. VanMeirvenne, C. Demanet, J. Brissinck, and K. Thielemens Bispecific antibody treatment of murine B cell lymphoma Cancer Immunol. Immunother. 45 1997 162
11. J. De Jonge, C. Heirman, M. de Veerman, S. Van Meirvenne, M. Moser, O. Leo, and K. Thielemans In vivo retargeting of T cell effector function by recombinant bispecific single chain Fv (anti-CD3×anti-idiotype) induces long-term survival in the murine BCL1 lymphoma model J. Immunol. 161 1998 1454
12. S.J. DeNardo, L.A. Kroger, M.R. MacKenzie, G.R. Mirick, S. Shen, and G.L. DeNardo Prolonged survival associated with immune response in a patient treated with Lym-1 mouse monoclonal antibody Cancer Biother. Radiopharm. 13 1998 1
13. J. Haimovich, T. Kukulansky, B. Weissman, and N. Hollander Rejection of tumors of the B cell lineage by idiotype-vaccinated mice Cancer Immunol. Immunother. 47 1999 330
14. N. Hamaguchi, A. Ellington, and M. Stanton Aptamer beacons for the direct detection of proteins Anal. Biochem. 294 2001 126
15. H.J. Hansen, G.L. Ong, H. Diril, A. Valdez, P.A. Roche, G.L. Griffiths, D.M. Goldenberg, and M.J. Mattes Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas Biochem. J. 320 1996 293
16. P.S. Hefty, and R.C. Kennedy Immunoglobulin variable regions as idiotype vaccines Infect. Dis. Clin. North Am. 13 1999 27
17. J. Hesselberth, M.P. Robertson, S. Jhaveri, and A.D. Ellington In vitro selection of nucleic acids for diagnostic applications J. Biotechnol. 74 2000 15
18. C.S. Hilger, M.C. Willis, M. Wolters, and W.A. Pieken Synthesis of Tc-99m-labeled modified RNA Tetrahedron Lett. 39 1998 9403
19. J. Honeychurch, A. Cruise, A.L. Tutt, and M.J. Glennie Bispecific Ab therapy of B-cell lymphoma: target cell specificity of antibody derivatives appears critical in determining therapeutic outcome Cancer Immunol. Immunother. 45 1997 171
20. F.J. Hsu, C.B. Caspar, D. Czerwinski, L.W. Kwak, T.M. Liles, A. Syrengelas, B. TaidiLaskowski, and R. Levy Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma-long-term results of a clinical trial Blood 89 1997 3129
21. B. Hwang, and S.W. Lee Improvement of RNA aptamer activity against myasthenic autoantibodies by extended sequence selection Biochem. Biophys. Res. Commun. 290 2 2002 656
22. S.D. Jayasena Aptamers: an emerging class of molecules that rival antibodies in diagnostics Clin. Chem. 45 1999 1628
23. S. Kohler, G. Prietl, J. Schmolling, U. Grunn, H.P. Fischer, H. Schlebusch, and U. Wagner Immunotherapy of ovarian carcinoma with the monoclonal anti-idiotype antibody ACA125-results of the Phase Ib study Geburtshilfe Frauenheilkd. 58 1998 180
24. N. Kumar, and S. Maiti Quadruplex to Watson-Crick duplex transition of the thrombin binding aptamer: a fluorescence resonance energy transfer study Biochem. Biophys. Res. Commun. 319 2004 759
25. B.K. Link, and G.L. Weiner Monoclonal antibodies in the treatment of human B-cell malignancies Leuk. Lymphoma 31 1998 237
26. S.J. Liu, Y.P. Sher, C.C. Ting, K.W. Liao, C.P. Yu, and M.H. Tao Treatment of B-cell lymphoma with chimeric IgG and single-chain Fv antibody interleukin-2 fusion proteins Blood 92 1998 2103
27. R.F. Macaya, J.A. Waldron, B.A. Beutel, H. Gao, M.E. Joesten, M. Yang, R. Patel, A.H. Bertelsen, and A.F. Cook Structural and functional characterization of potent antothrombotic oligonucleotides possessing both quadruplex and duplex motifs Biochemistry 34 1995 4478
28. D.G. Maloney, and O.W. Press Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies Oncology (N.Y.) 12 1998 63
29. K.A. Marshall, M.P. Robertson, and A.D. Ellington A biopolymer by any other name would bind as well: a comparison of the ligand-binding pockets of nucleic acids and proteins Curr. Biol. 5 1997 729
30. 54) and its domains by circular dichroism Mol. Microbiol. 24 1997 653
31. A. Murray, D.I.R. Spencer, S. Missailidis, G. Denton, and M.R. Price Rational design of ligands for the purification of anti-Muc1 monoclonal antibodies by peptide epitope affinity chromatography J. Pept. Res. 52 1998 375
32. A. Murray, S. Missailidis, and M.R. Price Epitope affinity chromatography and biophysical studies of monoclonal antibodies and recombinant antibody fragments J. Chromatogr. Sci. 40 2002 343
33. M.H.J. Ohlmeyer, R.N. Swanson, L.W. Dillard, J.C. Reader, G. Asuline, R. Kobayashi, M. Wigler, and W.C. Still Complex synthetic chemical libraries indexed with molecular tags Proc. Natl. Acad. Sci. U. S. A. 90 1993 10922
34. C.Y. Okada, C.P. Wong, D.W. Denney, and R. Levy TCR vaccines for active immunotherapy of T cell malignancies J. Immunol. 159 1997 5516
35. D.J. Patel, A.K. Suri, F. Jiang, L. Jiang, P. Fan, R.A. Kumar, and S. Nonin Structure, recognition and adaptive binding in RNA aptamer complexes J. Mol. Biol. 272 1997 645
36. M.L. Penichet, E.T. Harvill, and S.L. Morrison An IgG3-IL-2 fusion protein recognizing a murine B cell lymphoma exhibits effective tumor imaging and antitumor activity J. Interferon Cytokine Res. 18 1998 597
37. M.R. Price, J.A. Pugh, F. Hudecz, W. Griffiths, E. Jacobs, I.M. Symonds, A.J. Clarke, W.C. Chan, and R.W. Baldwin C595-a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas Br. J. Cancer 61 1990 681
38. M.R. Price, M.S. Sekowski, and S.J.B. Tendler Purification of antiepithelial mucin monoclonal-antibodies by epitope affinity-chromatography J. Immunol. Methods 139 1991 83
39. Price, M.R., Rye, P.D., Petrakou, E., Murray, A., Brady, K., Imai, S., Haga, S., Kiyozukam Y., Schol, D., Meulenbroek, M.F.A., Snijdewint, F.G.M., von Mensdorff-Pouilly, S., Verstraeten, R.A., Kenemans, P., Blockzjil, A., Nilsson, K., Nilsson, O., Reddish, M., Suresh, M.R., Koganty, R.R., Fortier, S., Baronic, L., Berg, A., Longenecker, M.B., Hilkens, J., Boer, M., Karanikas, V., McKenzie, I.F.C., Galanina, O.E., Simeoni, L.A., Ter-Grigoryan, A.G., Belyanchikov, I.M., Bovin, N.V., Cao, Y., Karsten, U., Dai, J., Allard, W.J., Davis, G., Yeung, K.K., Hanisch, F.G., Lloyd, K.O., Kudryashov, V., Sikut, R., Sikut, A., Zhang, K., Baeckstrom, D., Hansson, G.C., Reis, C.A., Hassan, H., Bennett, E.P., Claussen, H., Norum, L., Varaas, T., Kierulf, B., Nustad, K., Ciborowski, P., Konitzki, W.M., Magarian-Blander, J., Finn, O.J., Hilgers, J., 1998. Summary report on the ISOBM TD-4 Workshop: Analysis of 56 monoclonal antibodies against the MUC1 mucin-San Diego, Calif., November 17-23, 1996. Tumor Biol. 19, 1, Suppl.1.
40. V.L. Reichardt, C.Y. Okada, A. Liso, C.J. Benike, K.E. Stockerl-Goldstein, E.G. Engleman, K.G. Blume, and R. Levy Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma-a feasibility study Blood 93 1999 2411
41. S. Reinartz, H. Boerner, S. Koehler, A. Von Ruecker, H. Schlebusch, and U. Wagner Evaluation of immunological responses in patients with ovarian cancer treated with the anti-idiotype vaccine ACA125 by determination of intracellular cytokines-a preliminary report Hybridoma 18 1999 41
42. J.L. Schultze Vaccination as immunotherapy for B cell lymphoma Hematol. Oncol. 15 1997 129
43. G.P. Smith, and V.A. Petrenko Phage display Chem. Rev. 97 1997 391
44. R.G. Smith, S. Missailidis, and M.R. Price Purification of anti-MUC1 antibodies by peptide mimotope affinity chromatography using peptides derived from a polyvalent phage display library J. Chromatogr., B, Biomed. Sci. Appl. 766 2002 13
45. D.I.R. Spencer, S. Missailidis, G. Denton, A. Murray, K. Brady, C.I. De Matteis, M.S. Searle, S.J.B. Tendler, and M.R. Price Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides Biospectroscopy 5 1999 79
46. P. Terness, M. Welschof, G. Moldenhauer, M. Jung, L. Moroder, F. Kirchhoff, S. Kipriyanov, M. Little, and F. Opelz Idiotypic vaccine for treatment of human B-cell lymphoma. Construction of IgG variable regions from single malignant B-cells Hum. Immunol. 56 1997 17
47. M. Thurin, and T. Kieber-Emmons SA-Le(a) and tumor metastasis: the old prediction and recent findings Hybrid. Hybridomics 21 2002 111
48. Y.L. Tseng, R.L. Hong, M.H. Tao, and F.H. Chang Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model Int. J. Cancer 80 1999 723
49. C.E. Tucker, L.S. Chen, M.B. Judkins, J.A. Farmer, S.C. Gill, and D.W. Drolet Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys J. Chromatogr., B, Biomed. Sci. Appl. 732 1999 203
50. S. Weiss Fluorescence spectroscopy of single biomolecules Science 283 1999 1676
51. T.W. Wiegand, P.B. Williams, S.C. Dreskin, M.H. Jouvin, J.P. Kinet, and D. Tasset High-affinity oligonucleotide ligands to human IgE inhibit binding to Fce Receptor I J. Immunol. 157 1996 221
52. D. Wurflein, M. Dechant, B. Stockmeyer, A.L. Tutt, P.S. Hu, R. Repp, J.R. Kalden, J.G.J. van de Winkel, A.L. Epstein, T. Valerius, M. Glennie, and M. Gramatzki Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells Cancer Res. 58 1998 3051
53. M. Zuker, D.H. Mathews, and D.H. Turner J. Barciszewski B.F.C. Clark Algorithms and Thermodynamics for RNA Secondary Structure Prediction: A Practical Guide in RNA Biochemistry and Biotechnology NATO ASI Series 1999 Kluwer Academic Publishers